Risks for German stock market rise as “Overconfidence” kicks in

Written by Julien Mueller | 20 February 2017
Posted in Special research

The latest sentix survey reveals an issue: the sentix Overconfidence Index for the German Stock Index DAX has reached a new two-year high. Hence, the indicator signalises that investors have gained an extreme conviction that the market is trending upwards. A historical comparison indicates that the market has accumulated substantial risk.

Read more...

Stock market risk levels rise

Written by Julien Mueller | 13 February 2017
Posted in Special research

Investors’ confidence in the equity markets takes a beating. The respective sentix indicator for both, the US and European markets continues its decline. Although investors review their stance on equities, stock prices rally. Risks are lurking due to this discrepancy.

Read more...

Trump in focus

Written by Manfred Hübner | 31 January 2017
Posted in Special research

Introduction of the sentix Trumpometer®

The new US administration is increasingly viewed by investors as an important market factor. For this reason, sentix begins measuring this perception and assessing how the actions of the US administration in various policy areas affect the stock market from the investor's point of view. The first survey involved more than 1,200 professional and private investors.

Read more...

Crude burdens commodity asset class

Written by Julien Mueller | 23 January 2017
Posted in Special research

The sentix asset class sentiment for commodities has reached the highest level since 2012. At the same time, investors express falling conviction about further rising crude oil prices. Due to the material interconnection between crude price and the development of all commodities, risks arise.

Read more...

“Trumped”

Written by Julien Mueller | 16 January 2017
Posted in Special research

The sentix Sector Sentiment for European pharmaceutical stocks has hit the lowest level since 12 years ago. Within only a few weeks, investors’ perception has turned upside down. The latest remarks by president-elect Trump on drug pricing in the US has stirred up investors’ confidence. A short-term buying opportunity could arise.

Read more...